Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Contrast medium and preparation method thereof

A production method and contrast agent technology, applied in the medical field, can solve the problems of weak biotoxicity of contrast agents, increase of contrast agent biosafety risks, and inspection costs, and achieve no toxic side effects, good contrast effects, and good biocompatibility Effect

Active Publication Date: 2016-08-10
CHILDRENS HOSPITAL OF CHONGQING MEDICAL UNIV
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in order to obtain more comprehensive information, it is often necessary to use multiple contrast agents or composite contrast agents at the same time, which greatly increases the biosafety risk and inspection cost of contrast agents in the human body
[0005] At present, the contrast agents under research mainly include: gold nanoparticles (Au NPs), quantum dots, superparamagnetic iron oxide nanoparticles, near-infrared fluorescent dyes, etc., but these contrast agents still cannot solve the problem of poor contrast performance. and biotoxicity issues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Contrast medium and preparation method thereof
  • Contrast medium and preparation method thereof
  • Contrast medium and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] The contrast agent provided in this embodiment is mainly made of the following raw materials, in parts by weight: 2 parts of diphenylphosphoryl azide, 8 parts of dipalmitoylphosphatidylcholine, 3 parts of PEGylated phospholipids, and 2.5 parts of cholesterol , 1.5 parts of melanin and 8 parts of perfluoropropane.

[0058] The preparation method of the above-mentioned contrast agent comprises the following steps:

[0059] a. Mix diphenylphosphoryl azide, dipalmitoylphosphatidylcholine, phospholipids and cholesterol to obtain a mixed fat, dissolve the mixed fat in ether, and then use a 35KHz ultrasonic cleaner to act for 30 minutes to obtain an ether lipid solution, Wherein, the mass ratio of mixed fat and ether is 20:6.5;

[0060] b. Dissolve melanin in 0.08mol / L sodium hydroxide solution, then use a 35KHz ultrasonic cleaner to act for 12min, and then use 0.008mol / L hydrochloric acid to adjust the pH of the solution under the action of a dialysis bag with a molecular we...

Embodiment 2

[0065] The contrast agent provided in this embodiment is mainly made of the following raw materials, in parts by weight: 4 parts of diphenylphosphoryl azide, 12 parts of dipalmitoylphosphatidylcholine, 5 parts of PEGylated phospholipids, and 3.5 parts of cholesterol , 2.5 parts of melanin and 15 parts of perfluoropropane.

[0066] The preparation method of the above-mentioned contrast agent comprises the following steps:

[0067] a. Mix diphenylphosphoryl azide, dipalmitoylphosphatidylcholine, phospholipids and cholesterol to obtain a mixed lipid, dissolve the mixed lipid in ether, and then use a 45KHz ultrasonic oscillator to act for 5 minutes to obtain an ether lipid solution, Wherein, the mass ratio of mixed fat and ether is 20:11;

[0068] b. Dissolve melanin in 0.12mol / L potassium hydroxide solution, then use a 45KHz ultrasonic oscillator to act for 8 minutes, and then use 0.012mol / L hydrochloric acid to adjust the pH of the solution under the action of a dialysis bag wi...

Embodiment 3

[0076] The contrast agent provided in this embodiment is mainly made of the following raw materials in parts by weight: 3 parts of diphenylphosphoryl azide, 10 parts of dipalmitoylphosphatidylcholine, 4 parts of PEGylated phospholipids, and 3 parts of cholesterol , 2 parts of melanin and 11 parts of perfluoropropane.

[0077] The preparation method of the above-mentioned contrast agent comprises the following steps:

[0078] a. Mix diphenylphosphoryl azide, dipalmitoylphosphatidylcholine, phospholipids and cholesterol to obtain a mixed lipid, dissolve the mixed lipid in ether, and then use a 40KHz ultrasonic cleaner to act for 20 minutes to obtain an ether lipid solution, Wherein, the mass ratio of mixed fat and ether is 20:7.2;

[0079] b. Dissolve melanin in 0.1mol / L sodium hydroxide solution, then use a 40KHz ultrasonic cleaner to act for 10 minutes, and then use 0.01mol / L hydrochloric acid to adjust the pH of the solution under the action of a dialysis bag with a molecula...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a contrast medium and a preparation method thereof and relates to the technical field of medical treatment. The contrast medium is mainly prepared from, by weight, 2-4 parts of diphenyl azidophosphate, 8-12 parts of dipalmitoyl phosphatidyl choline, 3-5 parts of phospholipid, 2.5-3.5 parts of cholesterol, 1.5-2.5 parts of melanin and 8-15 parts of perfluoropropane, wherein the phospholipid refers to PEGylated phospholipid. The contrast medium has the advantages of good biocompatibility, no toxic or side effect and good contrast effect. The preparation method of the contrast medium is simple in steps and convenient to operate.

Description

technical field [0001] The invention relates to the field of medical technology, in particular to a contrast agent and a production method thereof. Background technique [0002] Medical imaging plays an important role in the diagnosis of cancer. Imaging techniques currently used in clinical practice include traditional X-ray, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), photoacoustic imaging, single photon emission computed tomography (SPECT), and positive imaging developed in recent years. Electron emission tomography (PET), etc. However, single molecular imaging technology has some insurmountable defects, such as limitations in time and space resolution, penetration depth and energy extension. A single imaging method is not enough to fully obtain tumor information, and the combination of multi-modal imaging technologies can complement each other's advantages and provide more accurate and comprehensive information for a clear diagnosis. [...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K49/22A61K49/00
CPCA61K49/00A61K49/221
Inventor 王冬杨珂姚远志张亮李娅莎钟英郑妍
Owner CHILDRENS HOSPITAL OF CHONGQING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com